Welcome to J3 Bioscience
Science designed for her
We’re rethinking how therapies are delivered for women - working with her biology, not against it.
J3 is advancing the LIV-Ring®, a patented long-acting intravaginal delivery platform that providers continuous, controlled release of active and functional ingredients to enable consistent local delivery, comfort, and convenience.
The LIV-Ring Platform designed for her
Our patented LIV-Ring platform is a next-generation intravaginal ring (IVR) system engineered for sustained, localized, or systemic delivery of active and functional ingredients for over-the-counter (OTC) indications.
J3’s LIV-Ring platform is a patented, long-acting intravaginal delivery system engineered for continuous, controlled release of active and functional ingredients. The IVR technology provides precise, controlled release kinetics — from days to multiple months — and is designed to support consistent performance, comfort, and convenience.
Inserted discreetly, the LIV-Ring resides within the vaginal canal and continuously delivers active and functional ingredients in a controlled manner, offering women a reliable, long-acting, and science-driven alternative to conventional oral dosage forms.
How it works
We’re reinventing how women access science-backed therapies
Designing better delivery systems
Most oral formulations are not designed for women and often interact with the gastrointestinal system, which may limit potency and create unwanted side effects. At J3, we’re designing smarter delivery systems that work with her biology, not against it.
Let’s make it easy for women
Imagine if women could access the benefits of the world’s most important active and functional ingredients – with fewer side effects, better absorption, and freedom from daily dosing.